ArticleBiometrics2022

Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects.

Yusha Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.